All material subject to strictly enforced copyright laws. © 2022 Managing IP is part of the Euromoney Institutional Investor PLC group.

Vaccines and Vidal: what pharma in-house are watching in 2022

Rani Mehta
January 14, 2022
Share
pharma2022cover.jpg

Innovator and generics counsel weigh in on key court cases and why they have high hopes for Kathi Vidal

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Tags

IP StrategyUnited StatesNewsPatentsNorth AmericaNorth AmericaJurisdictionsLife sciences
rani-mehta-300px.png
Rani Mehta
US Reporter Managing IP
Contact
Rani reports on all aspects of IP in the US and the Americas, particularly trademarks and copyright. Based in New York, she covers in-house and private practice lawyers' concerns and insights into the market.

More from across our site

AdobeStock_375704235_Editorial_Use_Only (1).jpg
If you want a 101 fix, legislative compromise is the only way
The US Supreme Court rejected an appeal on American Axle, dashing hopes of a judicial fix to patent eligibility uncertainty
Patrick Wingrove, July 01, 2022
ArtI.jpeg
Exclusive: US rejects copyright petition listing AI co-author
The Copyright Office refused to grant protection on the basis that the authorship couldn’t be distinguished from the final work produced by the program
Sukanya Sarkar, July 01, 2022
The supreme court rejected American Axle
This week in IP: SCOTUS rejects American Axle, Ireland commits to UPC referendum, and more
COVID vaccines top Clarivate’s new brands list; Fed Circuit reverses Coca-Cola’s TTAB win; Skechers sues Brooks; USPTO to retire Public PAIR tool; CCB sees cricket complaint
Patrick Wingrove, July 01, 2022
PTABVictoryApjsCOVER.jpg
Five former PTAB judges reveal how to succeed at the board
Lawyers should pay attention to APJs’ questions and remember that PTAB proceedings aren’t jury trials, say former PTAB judges
Rani Mehta, June 30, 2022
GalavaLargeJPEG.jpeg
USPTO cancels first marks under TMA
The USPTO cancelled ‘Galavava’ and 'Surfstar Wake' and partly cancelled ‘Heika’ this month
Rani Mehta, June 30, 2022
Patents
Patent rankings 2022
IP STARS 2022: The full patent rankings
We have published all the 2022 rankings of the leading firms for patent litigation and protection work
Chris Adams, June 30, 2022
Pharmaconcept
UK injunction shift forces pharma to change tack on litigation
In-house and private practice counsel say UK judges have raised the bar for preliminary injunction requests
Rory O’Neill, June 30, 2022
António Campinos wins new EPO term
António Campinos wins new EPO term (but tensions remain)
António Campinos will serve another five years as EPO president – perhaps he’ll calm unrest at the office in that time
Max Walters, June 29, 2022
AdobeStock_277739388.jpg
Firms must go beyond ‘empty’ LGBTQ gestures after pride month
LGBTQ IP lawyers say using rainbow colours and posting solidarity messages on social media must be followed by concrete action
Max Walters, June 29, 2022
Hidden links-comp.jpg
Why brand owners struggle with hidden links
Brand owners bemoan counterfeiters’ latest wheeze and say enforcement authorities should get more involved
Max Walters, June 29, 2022
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree